Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

XERIS PHARMACEUTICALS INC Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues0.00.1
            Revenue growth-69.8% 
Cost of goods sold0.00.0
Gross profit0.00.0
            Gross margin75.0%84.9%
Research and development20.210.2
General and administrative8.04.1
EBIT-26.6-13.2
            EBIT margin-166431.3%-24964.2%
Pre-tax income-26.6-13.2
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-26.6-13.2
            Net margin-165962.5%-24922.6%
 
Diluted EPS($13.09)($7.17)
Shares outstanding (diluted)2.01.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy